Predictors for permanent pacemaker implantation after core valve implantation in patients without preexisting ECG conduction disturbances: The role of a new echocardiographic index

International Journal of Cardiology

Volumn 172, Issue 3, 2014, Pages 601-603

  Toutouzas, Konstantinos ^a   Synetos, Andreas ^a   Tousoulis, Dimitris ^a   Latsios, George ^a   Brili, Stella ^a   Mastrokostopoulos, Antonis ^a   Karanasos, Antonios ^a   Sideris, Skevos ^a   Dilaveris, Polychronis ^a   Cheong, Adrian ^b   Yu, Cheuk Man ^b   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Aortic stenosis; Core valve implantation; Pacemaker

Indexed keywords

AGED; AORTA STENOSIS; COMPLETE HEART BLOCK; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FEMALE; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; IMAGE ANALYSIS; IMPLANTED HEART PACEMAKER; LETTER; MAJOR CLINICAL STUDY; MALE; PATHOLOGICAL ANATOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT RESPONSE; VERY ELDERLY; AORTIC VALVE STENOSIS; ARRHYTHMIAS, CARDIAC; ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL; ECHOCARDIOGRAPHY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROCEDURES;

AGED, 80 AND OVER; AORTIC VALVE STENOSIS; ARRHYTHMIAS, CARDIAC; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; PACEMAKER, ARTIFICIAL; PROGNOSIS; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 84900594178     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.01.091     Document Type: Article

References (17)

1. E. Grube, G. Schuler, and L. Buellesfeld et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome J Am Coll Cardiol 50 2007 69 76
2. N. Piazza, E. Grube, and U. Gerckens et al. A clinical protocol for analysis of the structural integrity of the Medtronic CoreValve System frame and its application in patients with 1-year minimum follow-up EuroIntervention 5 2010 680 686
3. A. Chieffo, G.L. Buchanan, and N.M. Van Mieghem et al. Transcatheter aortic valve implantation with the Edwards SAPIEN versus the Medtronic CoreValve Revalving system devices: a multicenter collaborative study: the PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration) J Am Coll Cardiol 61 2013 830 836
4. C. Di Mario, H. Eltchaninoff, and N. Moat et al. The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients EuroIntervention 8 2013 1362 1371
5. G. Latsios, U. Gerckens, and L. Buellesfeld et al. "Device landing zone" calcification, assessed by MSCT, as a predictive factor for pacemaker implantation after TAVI Catheter Cardiovasc Interv 76 2010 431 439
6. J. Baan Jr., Z.Y. Yong, and K.T. Koch et al. Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve prosthesis Am Heart J 159 2010 497 503
7. L. Roten, P. Wenaweser, and E. Delacretaz et al. Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation Am J Cardiol 106 2010 1473 1480
8. N.D. Ferreira, D. Caeiro, and L. Adao et al. Incidence and predictors of permanent pacemaker requirement after transcatheter aortic valve implantation with a self-expanding bioprosthesis Pacing Clin Electrophysiol 33 2010 1364 1372
9. P.E. Vardas, A. Auricchio, and J.J. Blanc et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association Eur Heart J 28 2007 2256 2295
10. E. Chorianopoulos, U. Krumsdorf, S.T. Pleger, H.A. Katus, and R. Bekeredjian Incidence of late occurring bradyarrhythmias after TAVI with the self-expanding CoreValve((R)) aortic bioprosthesis Clin Res Cardiol 101 2012 349 355
11. E. Grube, J.C. Laborde, and U. Gerckens et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study Circulation 114 2006 1616 1624
12. H. Jilaihawi, D. Chin, and M. Vasa-Nicotera et al. Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis Am Heart J 157 2009 860 866
13. N. Piazza, E. Grube, and U. Gerckens et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval EuroIntervention 4 2008 242 249
14. R.S. Gordon, J. Ivanov, G. Cohen, and A.L. Ralph-Edwards Permanent cardiac pacing after a cardiac operation: predicting the use of permanent pacemakers Ann Thorac Surg 66 1998 1698 1704
15. S. Dawkins, A.R. Hobson, P.R. Kalra, A.T. Tang, J.L. Monro, and K.D. Dawkins Permanent pacemaker implantation after isolated aortic valve replacement: incidence, indications, and predictors Ann Thorac Surg 85 2008 108 112
16. D. Erkapic, W.K. Kim, and M. Weber et al. Electrocardiographic and further predictors for permanent pacemaker requirement after transcatheter aortic valve implantation Europace 12 2010 1188 1190
17. A. Sinhal, L. Altwegg, and S. Pasupati et al. Atrioventricular block after transcatheter balloon expandable aortic valve implantation J Am Coll Cardiol 1 2008 305 309